Year To Quarter End Consolidated Statement Of Comprehensive Income

Fuji Pharma Co.,Ltd. - Filing #7357403

Concept 2023-10-01 to
2023-12-31
2022-10-01 to
2022-12-31
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
2,739,000,000 JPY
1,114,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-1,527,000,000 JPY
2,014,000,000 JPY
Deferred gains or losses on hedges
-25,000,000 JPY
-10,000,000 JPY
Foreign currency translation adjustment
81,000,000 JPY
-23,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-1,000,000 JPY
0 JPY
Other comprehensive income
-1,473,000,000 JPY
1,979,000,000 JPY
Comprehensive income
1,266,000,000 JPY
3,094,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
1,266,000,000 JPY
3,094,000,000 JPY
Comprehensive income attributable to non-controlling interests
0 JPY
0 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.